BridgeMD
New treatment option for Heel Spur Syndrome
Official title Optimal Radiotherapy - Heel Spur Syndrome - Randomized Clinical Trial
ClinicalTrials.gov ID: NCT07546240
What this study is testing
- What it's testing
- Heel Spur Syndrome (HSS), is a pathology characterized by chronic inflammation and degenerative changes that affect approximately 10% of adults. Although many patients respond to conservative care, about 30% experience persistent pain.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 40 and older
You may be able to join if
- Patients aged 40 years or older.
- Clinically confirmed painful Heel Spur Syndrome (plantar fasciitis) persisting for at least 3 months
- No effect from previous orthopaedic, physical, or analgesic treatments.
- General performance status ZUBROD 0-3.
- Exclusion of other local conditions.
You likely can't join if
- Prior radiotherapy for heel spur.
- Local use of corticosteroids within 4 weeks before planned radiotherapy.
- Previous trauma, surgery to the foot on the same side.
- Systemic diseases (eg collagen vascular disease).
- Pregnancy or breastfeeding.
- Lack of written informed consent
See the full eligibility criteria
- Patients aged 40 years or older.
- Clinically confirmed painful Heel Spur Syndrome (plantar fasciitis) persisting for at least 3 months
- No effect from previous orthopaedic, physical, or analgesic treatments.
- General performance status ZUBROD 0-3.
- Exclusion of other local conditions.
- Patient readiness for follow-up contact.
- Prior radiotherapy for heel spur.
- Local use of corticosteroids within 4 weeks before planned radiotherapy.
- Previous trauma, surgery to the foot on the same side.
- Systemic diseases (eg collagen vascular disease).
- Pregnancy or breastfeeding.
- Lack of written informed consent
The study team makes the final eligibility decision.
Where it's taking place
- Gliwice, Poland
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 40 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Gliwice, Poland. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.